Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apheresis PRP for Androgenic Alopecia
NCT07348315Phase 2Completed
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous apheresis platelet-rich plasma in androgenetic alopecia (AGA). Started Sep 2023; status: completed.
02
Drugs
autologous apheresis platelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07348315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07348315.